Hypoglycaemia is the most common side effect of insulin treatment, with severe hypoglycaemia affecting approximately 25% of patients with type 1 diabetes [1, 2], and is associated with increased morbidity and mortality [3, 4]. This evidence concerns the gene INS and type 1 diabetes mellitus.